Deniz Köksal

Prof. Dr. Deniz Köksal

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2005 in International Journal of Contemporary Hospitality Management
Verified
Journal Article
Closed access
PDF file
AAA. Akin Aksu
A. Akin Aksu
DKDeniz Köksal
Deniz Köksal
Purpose – To investigate the main expectations of students from the tourism industry who are studying at the Akdeniz University School of Tourism and Hotel Management in Antalya. Design/methodology/approach – A questionnaire containing 16 closed questions and a multi-item attitude scale was used for 689 students ranging from the first class to the fourth class. Findings – The results generally show negative perceptions and attitudes toward the tourism industry, but some positive perceptions and attitudes are also apparent. Positive emotions were usually mentioned by students who had chosen the tourism and hotel management school within their first three rank order in the university entrance exam, who had chosen the school willingly, and who had carried out their practical work experience outside Turkey. Research limitations/implications – It is not possible to generalize the findings to other tourism schools, but the findings can be evaluated as a useful source of information regarding the perceptions and attitudes of the sampled tourism students in Antalya, Turkey. Originality/value – The findings are of value for government officials, academicians, tourism professionals and also tourism students.

1 September 2005 in Postgraduate Medical Journal
Verified
Journal Article
Open access
PDF file
EÜE Ünsal
E Ünsal
SAS Aksaray
S Aksaray
DKDeniz Köksal
Deniz Köksal
TŞT Şipit
T Şipit
Objective: Reactive thrombocytosis is found in a number of clinical situations including infectious diseases such as pulmonary tuberculosis (PTB). To examine the possible role of interleukin (IL6) in reactive thrombocytosis and acute phase response in PTB this study measured serum IL6, C reactive protein (CRP), erythrocyte sedimentation rate (ESR), albumin concentrations in 62 PTB patients and 20 healthy volunteers. Method: PTB patients were divided into two groups based on thrombocyte counts. Twenty seven PTB patients with normal thrombocyte counts constituted group 1, 35 PTB patients with thrombocytosis constituted group 2, and 20 healthy volunteers constituted group 3. Results: The median IL6 concentration of group 1 was 12.8 pg/ml (95% CI: 12.1 to 56.9 pg/ml) and group 2 was 40.6 pg/ml (95% CI: 67.1 to 168.7 pg/ml). The comparison of IL6 concentrations in the three groups was significant (p = 0.0001). Patients in group 1 had a higher concentration of CRP (p = 0.0001) and lower concentration of albumin (p = 0.002) than group 3 whereas group 2 had higher concentration of CRP (p = 0.003) and lower concentration of albumin (p = 0.002) than group 1. Serum IL6 concentrations were significantly correlated with thrombocyte counts (p = 0.004, r = 0.36), CRP (p = 0.007, r = 0.34), and albumin concentrations (p = 0.005, r = −0.34). IL6 concentrations were significantly correlated with the number of involved zones (p = 0.005, r = 0.35) and acid fast bacilli positivity (p = 0.03, r = 0.27). Patients in group 2 had weight loss (p = 0.004), fever (p = 0.038), and night sweats (p = 0.007) more frequently than group 1. Also, group 2 had more extensive radiological findings (involved zones p = 0.001, bilateral disease p = 0.0001, presence of cavity p = 0.02) than group 1. Conclusions: IL6 might play a contributory part in reactive thrombocytosis and acute phase response in PTB.

20 August 2022 in Biomedical Signal Processing and Control
Verified
Journal Article
Closed access
FCFunda Cinyol
Funda Cinyol
UBUğur Baysal
Uğur Baysal
DKDeniz Köksal
Deniz Köksal
EBElif Babaoğlu
Elif Babaoğlu
SUSevinç Sarınç Ulaşlı
Sevinç Sarınç Ulaşlı

4 April 2013 in Journal of Cardiothoracic Surgery
Verified
Journal Article
Open access
PDF file
DKDeniz Köksal
Deniz Köksal
FDFunda Demirag
Funda Demirag
HBHulya Bayiz
Hulya Bayiz
OOOzlem Ozmen
Ozlem Ozmen
ETEbru Tatci
Ebru Tatci
EYErdal Yekeler
Erdal Yekeler
We aimed to investigate the correlation of maximum standardized uptake value (SUVmax) with pathological characteristics of primary tumor and to determine a Tumor/ Lymph node (T/LN) SUVmax ratio predicting metastasis to lymph nodes in NSCLC patients.

1 December 2006 in Respiratory Medicine
Verified
Journal Article
Closed access
SASükran Atikcan
Sükran Atikcan
EÜEbru Ünsal
Ebru Ünsal
FDFunda Demirag
Funda Demirag
DKDeniz Köksal
Deniz Köksal
AYAydın Yilmaz
Aydın Yilmaz

3 August 2021 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
ASAbdulsamet Sandal
Abdulsamet Sandal
EKElif Tuğçe Korkmaz
Elif Tuğçe Korkmaz
FAFunda Aksu
Funda Aksu
DKDeniz Köksal
Deniz Köksal
ZSZiya Toros Selçuk
Ziya Toros Selçuk
LÇLütfi Çöplü
Lütfi Çöplü
In this study, we aimed to evaluate the accuracy of the original and simplified pulmonary embolism (PE) severity index (PESI) to predict all-cause mortality after 30 days of acute PE diagnosis up to five years within consecutive sub-periods. Adult patients diagnosed with acute PE between January 1, 2003, and June 30, 2013, were retrospectively included. Data on baseline characteristics and mortality during a five-year follow-up were collected. The study included 414 patients (Male/Female=192/222). The median age at diagnosis was 61.5 (minimum–maximum, 18–93) years. Mortality rates were 13.3% at 30 days, 21.8% at 90 days, 32.6% at one year, and 51.0% at five years. Both stratification into risk classes according to the original PESI and low vs. high-risk classification of original and simplified PESI were significantly correlated with the 30-day, 31–90-day, 91-day-one-year, and one-five-year mortality. Significant PESI predictors for mortality were history of cancer [hazard ratio (HR): 3.31, 95% confidence interval (CI): 1.64–6.68; p=0.001] and heart failure (HR: 2.35, 95% CI: 1.04–5.32, p=0.041) at 31–90-day, history of cancer (HR: 5.45, 95% CI: 2.86–10.40, p<0.001) at 91-day-one-year, advancing age (HR: 1.04, 95% CI: 1.02–1.06, p<0.001) and history of cancer (HR: 5.53, 95% CI: 3.41–8.98, p<0.001) at one-five-year after acute PE diagnosis. All-cause long-term mortality in high-risk patients with acute PE according to original or simplified PESI significantly increased up to five years of follow-up. This survival disadvantage was mainly related to cancer and comorbidities rather than acute clinical manifestations. Future prospective studies are needed to demonstrate the effect of various comorbidities on long-term mortality in these patients.